1 / 12

JAMA Ophthalmology Journal Club Slides: Plus Disease in Retinopathy of Prematurity

JAMA Ophthalmology Journal Club Slides: Plus Disease in Retinopathy of Prematurity.

Download Presentation

JAMA Ophthalmology Journal Club Slides: Plus Disease in Retinopathy of Prematurity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. JAMA Ophthalmology Journal Club Slides:Plus Disease in Retinopathy of Prematurity Hewing NJ, Kaufman DR, Chan RVP, Chiang MF. Plus disease in retinopathy of prematurity: qualitative analysis of diagnostic process by experts. JAMA Ophthalmol. Published online May 23, 2013. doi:10.1001/jamaophthalmol.2013.135.

  2. Introduction • Plus disease diagnosis: • Determines need for treatment: Cryotherapy for Retinopathy of Prematurity (CRYO-ROP), Early Treatment for Retinopathy of Prematurity (ETROP). • “Venous dilation and arterial tortuosity of posterior vessels.” • Standard photograph: minimum amount of abnormality. • Newer “pre-plus” category. • Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP) and ETROP: ≥2 quadrants? Same 2 quadrants? • Which are the key vessels? Few severe vessels enough? • Both adequate tortuosity and dilation needed? • Does peripheral retina matter? Other features?

  3. Introduction • International Classification for Retinopathy of Prematurity (ICROP; 1980s) specified standard parameters: • Zone, stage, clock-hour extent, plus disease. • Previously: • Qualitative examination of retinal features. • What is plus disease? • Is “arterial tortuosity and venous dilation” an oversimplification? • Could this explain variability in diagnoses? • Study Objective: • To examine the diagnostic reasoning process of experts for plus disease in retinopathy of prematurity (ROP) using qualitative research techniques.

  4. Methods • Study Design: • Capture and encode detailed qualitative thoughts of experts during plus disease diagnosis. • Videotaped while reviewing 7 wide-angle images: (1) think-aloud protocol, (2) specific questions. • Participants: • 6 experts. • CRYO or ETROP principal investigators (5/6), ≥5 ROP articles (5/6), practiced before publication of CRYO-ROP findings (5/6). • Data Analysis: • Transcription, review, content analysis using qualitative research methods.

  5. Results: Think-Aloud Protocol Interexpert Agreement in Plus Disease Diagnosis by 6 ROP Experts From Reviewing 7 Wide-Angle Imagesa Imperfect agreement: rich data set for understanding rationale of diagnosis.

  6. Results: Think-Aloud Protocol Interexpert Agreement Among Experts Ranking Severity of Overall Vascular Abnormality, Arterial Tortuosity Alone, and Venous Dilation Alone in ROPa Are experts looking at different vascular features, or considering their importance differently?

  7. Results: Think-Aloud Protocol Intraexpert Agreement in Plus Disease Diagnosis by 6 ROP Experts From Reviewing 7 Wide-Angle Retinal Imagesa Intraexpert differences in plus disease diagnosis, significant inconsistencies while looking at the same image twice.

  8. Results Example: Qualitative Rationale Expert 1: “…looks like a very low gestational age baby; it’s taken quite a long time to get to this stage. There is a lot of arterial tortuosity [annotated]; there is a little bit of venous congestion in the superior temporal and superior nasal quadrant, more in the superior half of the retina [annotated]. By definition I think this has to be plus, because it’s 2 quadrants at least, and even the other quadrants aren’t normal...” Expert 2: “…there is a lot of tortuosity of the arteries; the veins are about 2 to 1. This could either be a pre-plus eye or a normal variant, depending on a quick look to the periphery. Curiously, there is a lot of tortuosity down here [annotated]; it looks like there is disease up here [annotated].” Expert 4: “…vessels seem to be branching excessively in that region [superonasal area annotated] and some increased tortuosity [superotemporal area annotated] as well, and this vein looks too fat [superotemporal area annotated]. If all the quadrants were like this quadrant [superotemporal] then it would be at least pre-plus and verging on plus, but since it’s only 1 quadrant that’s highly questionable, would not classify it as plus. I could see why some would call it pre-plus … I would call it no plus.”

  9. Results: Specific Questions Relationship Between Perceived Vascular Abnormality and Overall Plus Disease Diagnosisa Expert diagnosis is not always consistent (circled) with plus disease definitions. More studies and clarification to help?

  10. Results: Features Mentioned by Experts Retinal Features Considered by Experts During Plus Disease Diagnosisa

  11. Comment • There are inconsistencies in plus disease diagnosis. • Current concept of plus disease (“arterial tortuosity and venous dilation”) may be oversimplified. • Experts do not always appear to be considering the same retinal features. • Some experts seem to be considering features beyond arterial tortuosity and venous dilation in the posterior pole. • Findings may be applied to design of algorithms for computer-based diagnosis of plus disease.

  12. Contact Information • If you have questions, please contact the corresponding author: • Michael F. Chiang, MD, Departments of Ophthalmology and Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239 (chiangm@ohsu.edu). Funding/Support • This work was supported by grant EY19474 from the National Institutes of Health (Chiang), the Dr Werner Jackstaedt Foundation (Hewing), the Friends of Doernbecher Foundation (Chiang), unrestricted departmental funding from Research to Prevent Blindness (Chan and Chiang), and the St Giles Foundation (Chan). Conflict of Interest Disclosures • Dr Chiang is an unpaid member of the scientific advisory board for Clarity Medical Systems.

More Related